What’s New

Isarna Head of Preclinical R&D, Dr. Michel Janicot, is invited to give a presentation entitled "LNA-modified antisense oligonucleotides targeting TGF-β isoforms for the treatment of cancer and ocular diseases" at the 15th Annual EuroTIDES conference on Nov. 18 - 19 in Berlin (Germany). Experimental results from cell-based assays and in vivo PK/PD studies with selected antisense oligonucleotide drug candidates in ophthalmology models will also be presented in a poster session. Read more >>